Kinarus Therapeutics Holding AG
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on $137,000 over the previous period. Total operating expenses were $410,000.

Profit Margin

Kinarus Therapeutics Holding AG (SIX:PRFN.SW): Profit margin
2012 34.98M -403K -1.15%
2013 27.44M -650K -2.37%
2014 24.34M -821K -3.37%
2015 15.59M -1.63M -10.48%
2016 17.94M -1.01M -5.66%
2017 17.55M -260K -1.48%
2018 16.19M -762K -4.71%
2019 17.30M -940K -5.43%
2020 4.10M -16K -0.39%
2021 0 137K

PRFN.SW Income Statement (2012 – 2021)

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue
04.10M17.30M16.19M17.55M17.94M15.59M24.34M27.44M34.98M
Cost of revenue
03.93M16.75M14.57M15.55M15.74M13.98M21.75M24.07M29.02M
Gross profit
0172K552K1.62M2.00M2.2M1.61M2.59M3.36M5.96M
Operating exp.
Research and development
0000000000
Selling and marketing
076K368K1.52M1.54M1.46M1.39M1.57M2.04M2.57M
Total operating expenses
410K716K1.41M2.38M2.22M3.26M3.2M2.88M4.08M5.02M
Operating income
-410K2K-887K-765K-209K-842K-1.63M-380K-3.03M937K
Other income (expenses), net
267K-9K-56K-29K-36K-39K-36K1K2.28M-1.23M
Income before tax
-143K-7K-943K-794K-245K-881K-1.67M-379K-753K-298K
Income tax expense
-280K9K-3K-32K15K135K-39K442K-103K105K
Net income
137K-16K-940K-762K-260K-1.01M-1.63M-821K-650K-403K
Earnings per share
Basic EPS
0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Diluted EPS
0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source